ABERRANT SPLICING DURING ERYTHROID DIFFERENTIATION IN SF3B1 MUTATED SIDEROBLASTIC

被引：0

作者：

Conte, S. ^{[1
]}

Vesterlund, L. ^{[2
,3
]}

Katayama, S. ^{[2
,3
,4
]}

Karimi, M. ^{[1
]}

Unneberg, P. ^{[5
]}

Papaemmanuil, E. ^{[6
]}

Jansson, M. ^{[1
]}

Mortera-Blanco, T. ^{[1
]}

Dimitriou, M. ^{[1
]}

Sander, B. ^{[7
]}

Skoog, T. ^{[2
,3
]}

Campbells, P. ^{[6
]}

Kere, J. ^{[2
,3
]}

Hellstrom-Lindberg, E. ^{[1
]}

机构：

[1] Ctr Hematol & Regenerat Med HERM, Dept Med, Huddinge, Sweden

[2] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden

[3] Karolinska Inst, Ctr Biosci, Stockholm, Sweden

[4] Sci Life Lab, Stockholm, Sweden

[5] Sci Life Lab, Dept Biochem & Biophys, Stockholm, Sweden

[6] Wellcome Trust Sanger Inst, Canc Genet & Genom, Cambridge, England

[7] Karolinska Univ Hosp, Div Pathol, Dept Lab Med, Stockholm, Sweden

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P168

引用

页码：73 / 74

页数：2

共 50 条

[31] Review of clinical and genetic variables of SF3B1 mutated uveal melanoma
Drabarek, W.
van Poppelen, N.
Smit, K. N.
Verdijk, R. M.
Naus, N.
Mensink, H.
Paridaens, D.
de Klein, A.
Kilic, E.
ACTA OPHTHALMOLOGICA, 2018, 96 : 47 - 48
[32] Disruption of Intracellular Metal Homeostasis As a Vulnerability in SF3B1 Mutated AML
Moison, Celine
Gracias, Deanne
Schmitt, Julie
Girard, Simon
Fortier, Simon
Boivin, Isabel
Spinella, Jean-Francois
Macrae, Tara
Ruel, Rejean
Hebert, Josee
Marinier, Anne
Sauvageau, Guy
BLOOD, 2022, 140 : 10680 - 10681
[33] Heterozygous Hotspot SF3B1 Mutations Found in Myelodysplastic Syndromes Downregulate Genes Involved in Differentiation of Erythroid Cells
Buonamici, Silvia
Darman, Rachel
Perino, Samantha
Agrawal, Anant
Peng, Shouyong
Seiler, Michael
Lim, Kian Huat
Bhavsar, Erica B.
Feala, Jacob
Obeng, Esther A.
Bailey, Suzanna
Chan, Betty
Fekkes, Peter
Keaney, Gregg F.
Kumar, Pavan
Kunii, Kaiko
Lee, Linda
Mackenzie, Crystal
Matijevic, Mark
Mizui, Yoshiharu
Myint, Khin
Park, Eunice
Pazolli, Ermira
Thomas, Michael
Wang, John
Warmuth, Markus
Yu, Lihua
Zhu, Ping
Furman, Richard R.
Ebert, Benjamin L.
Smith, Peter G.
BLOOD, 2015, 126 (23)
[34] Targeting SF3B1 mediated splicing control in chronic lymphocytic leukemia
Chen, Rong
Plunkett, William
Kipps, Thomas J.
Wu, Catherine J.
Keating, Michael
Chen, Yuling
Rassenti, Laura
Gruber, Michaela
Ghia, Emanuela
Qi, Yuan
Su, Xiaoping
Wong, Jessica
LEUKEMIA & LYMPHOMA, 2017, 58 : 219 - 219
[35] SF3B1 Splicing Mutation in the Context of Therapy-Related MDS
Volpe, Virginia
Al Ali, Najla
Padron, Eric
Sallman, David
Komrokji, Rami
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S320 - S320
[36] The splicing factor SF3B1 is involved in brown adipocyte thermogenic activation
Castella, Moises
Mestres-Arenas, Alberto
Gavalda-Navarro, Aleix
Blasco-Roset, Albert
Quesada-Lopez, Tania
Romero-Carraminana, Ines
Giralt, Marta
Villarroya, Francesc
Cereijo, Ruben
BIOCHEMICAL PHARMACOLOGY, 2024, 220
[37] MicroRNA biogenesis is broadly disrupted by inhibition of the splicing factor SF3B1
Velasco, Angela Downie Ruiz
Parsons, Aimee L.
Heatley, Matthew C.
Martin, Athena R. G.
Smart, Alfredo D.
Shah, Niraj
Jopling, Catherine L.
NUCLEIC ACIDS RESEARCH, 2024, 52 (15) : 9210 - 9229
[38] SF3B1 Mutation Causes Aberrant Splicing and Downregulation of PPP2R5A in Chronic Lymphocytic Leukemia
Han, Qimei
Deng, Libin
Pei, Lirong
Choi, Jeong-Hyeon
Jin, Victor
Shi, Huidong
BLOOD, 2017, 130
[39] Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing
Zhang, Ling
Zhang, Xiaojuan
Zhang, Haitao
Liu, Feng
Bi, Yanghui
Zhang, Yanyan
Cheng, Caixia
Liu, Jing
BREAST CANCER, 2020, 27 (03) : 464 - 476
[40] Understanding the Role of Mutations in SF3B1 and Splicing in Chronic Lymphocytic Leukemia
Wu, Catherine J.
BLOOD, 2012, 120 (21)

← 1 2 3 4 5 →